Lifeboat Foundation

This is an old study with new data from UK Biobank.

People more or less keeping to NHS guidelines at higher risk than those who eat little.

28 votes and so far on Reddit.

Mars has water trapped in the polar ice caps. More water may lie just beneath the surface. A new study suggests that water also flows on the surface.

Next-generation, low-power optical data transmission may rely on polarization rather than switching laser pulses on and off.

Software that rapidly analyses digital devices and builds a list of a suspect’s known associates could be a powerful tool for solving crimes.

Qualcomm said it plans to begin testing its new Cloud AI 100 chip with partners such as Microsoft Corp later this year, with mass production likely to begin in 2020.

Qualcomm’s new chip is designed for what artificial intelligence researchers call “inference” – the process of using an AI algorithm that has been “trained” with massive amounts of data in order to, for example, translate audio into text-based requests.

Analysts believe chips for speeding up inference will be the largest part of the AI chip market.

Continue reading “Qualcomm Aims for Quantum AI Chips” »

Kepler-47 is a roughly 3.5-billion-year-old system located 3,340 light-years from Earth. One of its stars is quite sunlike, but the other is considerably smaller, harboring just one-third the mass of our sun. The two stars orbit their common center of mass once every 7.45 Earth days.

Back in 2012, Welsh and his colleagues, led by fellow SDSU astronomer Jerome Orosz, announced the discovery of two planets circling the two stars. These worlds, Kepler-47b and Kepler-47c, both have two suns in their skies, just like Luke Skywalker’s home planet of Tatooine in the “Star Wars” universe.

Creating a lithium-ion battery that can charge in a matter of minutes but still operate at a high capacity is possible, according to research from Rensselaer Polytechnic Institute just published in Nature Communications. This development has the potential to improve battery performance for consumer electronics, solar grid storage, and electric vehicles.

Chemotherapy helps two out of three patients achieve remission. And recently, drug developers designed a new attack, one intended to target the patient’s malfunctioning genes, reclaim their hijacked cells, and halt growth. But this kind of drug development can result in more errors in trials, and can take years to get from lab to patient.

Now, in a paper published in Nature Chemical Biology, Harvard University Assistant Professor of Chemistry and Chemical Biology Brian Liau reveals why certain AML drugs only work some of the time. With his new technique, Liau and team expose more intimate details about the drug-body relationship and, in the process, disprove previous assumptions about how AML drugs work.